Zeidel M L, Jabs K, Kikeri D, Silva P
Department of Medicine, Veterans Administration Hospital, West Roxbury 02132.
Am J Physiol. 1990 Jun;258(6 Pt 2):F1584-91. doi: 10.1152/ajprenal.1990.258.6.F1584.
Kinins promote natriuresis in vivo, at least in part by altering Na+ transport in the collecting duct. Using freshly prepared suspensions of rabbit inner medullary collecting duct (IMCD) cells, we have examined the effects of kinins on Na+ transport using measurements of oxygen consumption (QO2) and isotopic Na+ uptake. Bradykinin (BK) inhibited IMCD cell QO2 by 24.7 +/- 0.9% without significantly reducing QO2 in cells derived from the outer medullary collecting duct. BK and kallidin half-maximally inhibited QO2 at concentrations in the 10(-12)-10-(-11) M range; beta 1-receptor agonists did not alter QO2, and beta 1-receptor antagonism did not reduce the effect of kinins. These observations indicate that the actions of kinins on IMCD cells are mediated by beta 2-receptors or a distinct subclass. Several observations indicate that kinins reduce QO2 by inhibiting Na+ entry: in the absence of Na+, BK did not reduce QO2; BK inhibition of QO2 was not additive with ouabain, amiloride, atrial natriuretic peptide (ANP), or 8-bromoguanosine 3',5'-cyclic monophosphate and was abolished in the presence of the cation ionophore amphotericin B. Measurements of isotopic Na+ uptake demonstrated that BK reduced the initial rate of Na+ entry by 58%; BK inhibited the amiloride-sensitive component of conductive Na+ uptake. Because ANP inhibits conductive Na+ entry in IMCD cells via stimulation of cGMP accumulation, the effect of BK on cGMP levels was determined. Unlike ANP, BK did not increase cGMP levels, indicating that transport effects of kinins in IMCD are not mediated by cGMP. Thus kinins directly inhibit conductive Na+ entry in IMCD cells at concentrations suggestive of a physiological effect.(ABSTRACT TRUNCATED AT 250 WORDS)
激肽在体内可促进尿钠排泄,至少部分是通过改变集合管中的钠转运来实现的。我们使用新鲜制备的兔内髓集合管(IMCD)细胞悬液,通过测量氧耗量(QO2)和同位素钠摄取,研究了激肽对钠转运的影响。缓激肽(BK)使IMCD细胞的QO2降低了24.7±0.9%,而对外髓集合管来源的细胞的QO2没有显著降低。BK和胰激肽在10(-12)-10(-11) M浓度范围内对QO2的抑制作用达到半数最大效应;β1受体激动剂不改变QO2,β1受体拮抗剂也不减弱激肽的作用。这些观察结果表明,激肽对IMCD细胞的作用是由β2受体或一个独特的亚类介导的。多项观察表明,激肽通过抑制钠内流来降低QO2:在无钠的情况下,BK不降低QO2;BK对QO2的抑制作用与哇巴因、氨氯地平、心房利钠肽(ANP)或8-溴鸟苷3',5'-环磷酸不具有相加性,并且在阳离子离子载体两性霉素B存在时被消除。同位素钠摄取测量表明,BK使钠内流的初始速率降低了58%;BK抑制了钠传导性摄取中对氨氯地平敏感的成分。由于ANP通过刺激cGMP积累来抑制IMCD细胞中的钠传导性内流,因此测定了BK对cGMP水平的影响。与ANP不同,BK不增加cGMP水平,这表明激肽在IMCD中的转运作用不是由cGMP介导的。因此,激肽在暗示具有生理效应的浓度下直接抑制IMCD细胞中的钠传导性内流。(摘要截断于250字)